Terminalia chebula (Chebulic acid)

Accelerate your CDMO or DTC pipeline. Map the exact physiochemical constraints, bioavailability synergies, and optimal delivery mechanisms for Terminalia chebula (Chebulic acid).

Chebulic acid functions as a potent hepatoprotective and antioxidant agent by modulating oxidative stress pathways and inhibiting pro-inflammatory cytokines through the neutralization of reactive oxygen species and the induction of endogenous antioxidant enzymes.

Verified Molecular Profiling (NIH PubChem)

PubChem CID

440704

Molecular Weight

320.5 g/mol

XLogP3 (Lipophilicity)

5.2

IUPAC Name

(3R)-17-(1-hydroxyethyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol

Pharmacokinetic Synergies & Enhancers

Proven Synergy Pairings

Terminalia bellerica for synergistic antioxidant and hepatoprotective effects via complementary phenolic profiles
Phyllanthus emblica for enhanced gastrointestinal motility and cytoprotective synergy in Ayurvedic Triphala formulations

Biological Formulation Enhancers

Piperine for increased intestinal permeability and inhibition of glucuronidation to improve systemic bioavailability
Quercetin for potential inhibition of efflux transporters and synergistic radical scavenging activity

Delivery System Constraints & Modeling

Every active compound behaves uniquely based on the physical matrix it is suspended in. Below are the known physical chemistry challenges for Terminalia chebula (Chebulic acid) across standard consumer modalities.

💊 Standard Capsules

The hygroscopic nature of Chebulic acid requires moisture-resistant HPMC capsules to prevent clumping and maintain long-term stability of the dry extract.

🍬 Gummy & Pectin Formats

High concentrations of polyphenols like Chebulic acid can cause significant astringency and protein precipitation in gelatin or pectin matrices, complicating flavor masking and texture consistency.

🔬 Thin-Film Oral Strips

The high therapeutic dose required for Chebulic acid often exceeds the 20-30mg payload capacity of thin-film oral strips, limiting its application to concentrated micro-dosing.

For Brand Founders

Formulate with Terminalia chebula (Chebulic acid)

Ready to launch a product featuring Terminalia chebula (Chebulic acid)? Skip months of expensive wet-lab iterations. Generate a manufacturer-ready formulation in hours, instantly screened for physical incompatibilities and global regulatory compliance.

Build Science-Backed Formulation

Efficacy Evidence

Maximize Terminalia chebula (Chebulic acid) Bioavailability

Need absolute proof that your Terminalia chebula (Chebulic acid) extract actually absorbs? Stop blindly combining generic powders. Run a physics-based PBPK simulation to mathematically engineer peak clinical efficacy and targeted plasma concentrations.

Simulate Bioavailability

For R&D Labs & CDMOs

Terminalia chebula (Chebulic acid) Degradation Testing

Is your Terminalia chebula (Chebulic acid) payload degrading in the capsule before the expiration date? Stop waiting for costly bench testing. Run an accelerated digital twin to precisely model oxidation pathways and pH shifts before finalizing a manufacturing run.

Model Active Degradation